Mesalazine

Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis

Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis.

Minocyclin in Ulcerative Colitis as Added on Therapy

Therapeutic Effect of Methalazine on 27 Cases of Suppurative Hidradenitis

Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis.

Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis

Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis

Effectiveness of Fecal Microbiota Transplantation as add-on Therapy in Mild-to-moderate Ulcerative Colitis

Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment

Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Predicting Response to Standardized Pediatric Colitis Therapy

The Safety and Efficacy of TET Enema in the Treatment of UC

QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)

Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis

Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis

Mesalazine With Hydrocortisone Sodium Succinate Enema for 4-Week Treatment in Patients With Ulcerative Colitis

Mesalazine Treatment in IBS (The MIBS Study)

Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an "in Vivo" Evaluation of the Molecular Effects on β-catenin Signaling Pathway.

OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis

Mesalazine Effects in Sporadic Colorectal Adenoma Patients